MARKET

DERM

DERM

Dermira
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.71
-0.05
-0.27%
After Hours: 18.69 -0.02 -0.11% 19:39 01/24 EST
OPEN
18.79
PREV CLOSE
18.76
HIGH
18.79
LOW
18.69
VOLUME
4.45M
TURNOVER
--
52 WEEK HIGH
19.48
52 WEEK LOW
5.25
MARKET CAP
1.02B
P/E (TTM)
-4.0853
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of DERM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

DERM News

  • SHAREHOLDER ALERT: WeissLaw LLP Reminds HABT, DERM, and MFSF Shareholders About Its Ongoing Investigations
  • GlobeNewswire.1d ago
  • H.C. Wainwright Downgrades Dermira to Neutral, Announces $18.75 Price Target
  • Benzinga.3d ago
  • What Company Will Eli Lilly Buy Next?
  • MotleyFool.com.3d ago
  • MERGER ALERT - INST, DERM, and PRMW: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
  • ACCESSWIRE.6d ago

More

Industry

Biotechnology & Medical Research
-2.64%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About DERM

Dermira, Inc. is a biopharmaceutical company. The Company is focused on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The Company’s portfolio consists of QBREXZA and Lebrikizumab. QBREXZA is a once-daily anticholinergic cloth for the treatment of primary axillary hyperhidrosis in adult and pediatric patients. QBREXZA is applied directly to the skin and is designed to block underarm sweat production by inhibiting sweat gland activation. Lebrikizumab is an injectable, humanized monoclonal antibody targeting interleukin 13 (IL-13) that the Company is developing for the treatment of moderate-to-severe atopic dermatitis.
More

Webull offers Dermira Inc (DERM) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.